Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,293 publicly listed stocks with a combined market cap of $2.10 Trillion. Vera Therapeutics Inc leads the sector with a market cap of $2.36 Billion. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$2.10 Trillion
Companies Listed
1,293
Largest Company
Vera Therapeutics Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 151 |
Vera Therapeutics Inc
NASDAQ:VERA |
$2.36 Billion | $2.36 Billion | USA | $33.67 | -1.12% | -6.19% | 56.13 Million |
| 152 |
SOLENO THERAPEUT. DL-001
F:6XC |
$2.31 Billion | €1.97 Billion | Germany | €44.86 | +1.70% | +1.20% | 130.00 |
| 153 |
Sellas Life Sciences Group Inc
NASDAQ:SLS |
$2.28 Billion | $2.28 Billion | USA | $11.29 | -3.71% | -18.54% | 179.52 Million |
| 154 |
Nektar Therapeutics
NASDAQ:NKTR |
$2.28 Billion | $2.28 Billion | USA | $66.64 | -2.72% | -10.18% | 14.39 Million |
| 155 |
ABL Bio Inc
KQ:298380 |
$2.25 Billion | ₩3.32 Trillion | Korea | ₩59300.00 | -8.63% | -16.60% | 6.43 Million |
| 156 |
Ocular Therapeutix Inc
NASDAQ:OCUL |
$2.24 Billion | $2.24 Billion | USA | $10.19 | -4.94% | -4.23% | 64.62 Million |
| 157 |
89bio Inc
NASDAQ:ETNB |
$2.20 Billion | $2.20 Billion | USA | $14.84 | +0.00% | +0.27% | 140.50 Million |
| 158 |
Palvella Therapeutics, Inc
NASDAQ:PVLA |
$2.18 Billion | $2.18 Billion | USA | $151.22 | -0.31% | -3.83% | 4.57 Million |
| 159 |
BrightGene Bio Medical Technology C
SHG:688166 |
$2.14 Billion | CN¥14.65 Billion | China | CN¥34.62 | -2.37% | -7.06% | 315.41 Million |
| 160 |
Trevi Therapeutics Inc
NASDAQ:TRVI |
$2.14 Billion | $2.14 Billion | USA | $15.04 | -5.35% | -12.86% | 35.14 Million |
| 161 |
Sinocelltech Group Ltd
SHG:688520 |
$2.09 Billion | CN¥14.25 Billion | China | CN¥32.00 | -1.60% | -5.58% | 70.96 Million |
| 162 |
Kodiak Sciences Inc
NASDAQ:KOD |
$2.07 Billion | $2.07 Billion | USA | $32.99 | -0.45% | -6.70% | 14.44 Million |
| 163 |
LegoChem Biosciences Inc
KQ:141080 |
$2.07 Billion | ₩3.05 Trillion | Korea | ₩83700.00 | -1.18% | -9.32% | 5.48 Million |
| 164 |
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH |
$2.06 Billion | $2.06 Billion | USA | $16.13 | -1.71% | +0.31% | 22.18 Million |
| 165 |
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP |
$2.05 Billion | $2.05 Billion | USA | $42.68 | -3.00% | -6.75% | 6.58 Million |
| 166 |
UroGen Pharma Ltd
NASDAQ:URGN |
$2.04 Billion | $2.04 Billion | USA | $41.74 | -2.11% | -5.33% | 19.27 Million |
| 167 |
Nuvation Bio Inc
NYSE:NUVB |
$2.03 Billion | $2.03 Billion | USA | $5.80 | -2.36% | -14.83% | 129.27 Million |
| 168 |
REMEGEN CO. LTD YC 1
F:REG |
$2.02 Billion | €1.73 Billion | Germany | €8.29 | +1.10% | -3.04% | 0.00 |
| 169 |
Zenas BioPharma, Inc. Common Stock
NASDAQ:ZBIO |
$1.98 Billion | $1.98 Billion | USA | $31.93 | +0.06% | -2.89% | 16.51 Million |
| 170 |
Agios Pharm
NASDAQ:AGIO |
$1.96 Billion | $1.96 Billion | USA | $32.81 | -1.23% | -0.88% | 19.80 Million |
| 171 |
SK Bioscience Co Ltd
KO:302440 |
$1.95 Billion | ₩2.88 Trillion | Korea | ₩36750.00 | -2.78% | -2.26% | 1.95 Million |
| 172 |
Anhui Anke BioTech Group
SHE:300009 |
$1.95 Billion | CN¥13.30 Billion | China | CN¥7.96 | -1.36% | -3.86% | 1.21 Billion |
| 173 |
Gempharmatech Co. Ltd. A
SHG:688046 |
$1.94 Billion | CN¥13.27 Billion | China | CN¥32.37 | -1.37% | +3.68% | 342.49 Million |
| 174 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
$1.94 Billion | $1.94 Billion | USA | $20.72 | -0.96% | -7.91% | 69.90 Million |
| 175 |
Shanghai Medicilon Inc
SHG:688202 |
$1.94 Billion | CN¥13.23 Billion | China | CN¥98.50 | +1.56% | +7.65% | 188.37 Million |
| 176 |
Nurix Therapeutics Inc
NASDAQ:NRIX |
$1.93 Billion | $1.93 Billion | USA | $24.83 | -2.70% | -5.01% | 27.34 Million |
| 177 |
ADMA Biologics Inc
NASDAQ:ADMA |
$1.93 Billion | $1.93 Billion | USA | $8.61 | -5.80% | -10.50% | 47.86 Million |
| 178 |
Mesoblast Ltd
NASDAQ:MESO |
$1.91 Billion | $1.91 Billion | USA | $14.74 | -1.86% | -14.90% | 4.62 Million |
| 179 |
GH Research PLC
NASDAQ:GHRS |
$1.89 Billion | $1.89 Billion | USA | $27.55 | -1.22% | -2.41% | 5.45 Million |
| 180 |
Mesoblast Ltd
AU:MSB |
$1.89 Billion | AU$2.67 Billion | Australia | AU$2.06 | -2.83% | -7.62% | 60.98 Million |
| 181 |
Galapagos NV ADR
NASDAQ:GLPG |
$1.89 Billion | $1.89 Billion | USA | $28.68 | -1.58% | -1.65% | 4.67 Million |
| 182 |
Jinyu Bio-Technology Co Ltd
SHG:600201 |
$1.88 Billion | CN¥12.86 Billion | China | CN¥11.69 | -1.27% | -4.96% | 297.10 Million |
| 183 |
Biohaven Ltd.
NYSE:BHVN |
$1.86 Billion | $1.86 Billion | USA | $12.34 | -2.37% | -21.35% | 78.75 Million |
| 184 |
Inner Mongolia Furui Med Sci
SHE:300049 |
$1.85 Billion | CN¥12.65 Billion | China | CN¥47.92 | +6.56% | +16.82% | 221.45 Million |
| 185 |
Generate Biomedicines, Inc. Common Stock
NASDAQ:GENB |
$1.84 Billion | $1.84 Billion | USA | $16.19 | +1.19% | -1.22% | 33.83 Million |
| 186 |
ZAI LAB LTD0000006
F:1ZLB |
$1.82 Billion | €1.56 Billion | Germany | €2.08 | +0.00% | -5.45% | 0.00 |
| 187 |
Stoke Therapeutics Inc
NASDAQ:STOK |
$1.82 Billion | $1.82 Billion | USA | $28.15 | -4.90% | -5.57% | 18.39 Million |
| 188 |
Nanobiotix
NASDAQ:NBTX |
$1.79 Billion | $1.79 Billion | USA | $35.26 | -1.32% | -9.12% | 4.05 Million |
| 189 |
Zymeworks Inc. Common Stock
NASDAQ:ZYME |
$1.79 Billion | $1.79 Billion | USA | $26.05 | -2.98% | -10.76% | 16.40 Million |
| 190 |
Vir Biotechnology Inc
NASDAQ:VIR |
$1.77 Billion | $1.77 Billion | USA | $10.44 | -3.02% | -8.30% | 45.26 Million |
| 191 |
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX |
$1.76 Billion | $1.76 Billion | USA | $61.08 | +2.67% | -1.04% | 9.31 Million |
| 192 |
Lakefront Biotherapeutics NV
NASDAQ:LKFT |
$1.76 Billion | $1.76 Billion | USA | $26.81 | +0.00% | -6.94% | 5.95 Million |
| 193 |
Kailera Therapeutics, Inc. Common Stock
NASDAQ:KLRA |
$1.74 Billion | $1.74 Billion | USA | $13.45 | -2.18% | -17.13% | 18.71 Million |
| 194 |
Kardigan, Inc. Common Stock
NASDAQ:KARD |
$1.74 Billion | $1.74 Billion | USA | $18.56 | -2.57% | -10.98% | 7.44 Million |
| 195 |
Recursion Pharmaceuticals Inc
NASDAQ:RXRX |
$1.73 Billion | $1.73 Billion | USA | $3.24 | -4.99% | -10.74% | 360.32 Million |
| 196 |
Vericel Corp Ord
NASDAQ:VCEL |
$1.73 Billion | $1.73 Billion | USA | $39.72 | +0.30% | -1.17% | 11.47 Million |
| 197 |
Hugel Inc
KQ:145020 |
$1.72 Billion | ₩2.54 Trillion | Korea | ₩235500.00 | +1.51% | -3.09% | 850.82K |
| 198 |
Viridian Therapeutics Inc
NASDAQ:VRDN |
$1.71 Billion | $1.71 Billion | USA | $21.83 | -1.67% | -4.76% | 30.16 Million |
| 199 |
Neuren Pharmaceuticals Ltd
AU:NEU |
$1.70 Billion | AU$2.40 Billion | Australia | AU$20.72 | +0.97% | +1.27% | 12.78 Million |
| 200 |
RAPT Therapeutics Inc
NASDAQ:RAPT |
$1.68 Billion | $1.68 Billion | USA | $58.01 | +0.00% | +0.13% | 98.79 Million |
| 201 |
PHARVARIS N.V. EO -12
F:9EN |
$1.67 Billion | €1.43 Billion | Germany | €33.25 | +1.53% | +9.74% | 202.00 |
| 202 |
Concord Biotech Limited
NSE:CONCORDBIO |
$1.67 Billion | Rs154.10 Billion | India | Rs1473.00 | -2.17% | +3.94% | 3.95 Million |
| 203 |
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497 |
$1.65 Billion | CN¥11.27 Billion | China | CN¥20.92 | +3.26% | +11.81% | 719.76 Million |
| 204 |
Septerna, Inc. Common Stock
NASDAQ:SEPN |
$1.64 Billion | $1.64 Billion | USA | $38.86 | -1.74% | +5.74% | 9.75 Million |
| 205 |
AnaptysBio Inc
NASDAQ:ANAB |
$1.62 Billion | $1.62 Billion | USA | $54.68 | +1.05% | -3.73% | 10.24 Million |
| 206 |
Taysha Gene Therapies Inc
NASDAQ:TSHA |
$1.62 Billion | $1.62 Billion | USA | $5.06 | +1.00% | -9.64% | 55.81 Million |
| 207 |
Syndax Pharmaceuticals Inc
NASDAQ:SNDX |
$1.62 Billion | $1.62 Billion | USA | $18.09 | -1.42% | -12.01% | 30.09 Million |
| 208 |
Immunocore Holdings Ltd
NASDAQ:IMCR |
$1.61 Billion | $1.61 Billion | USA | $31.78 | -2.11% | -12.05% | 8.90 Million |
| 209 |
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
$1.60 Billion | CN¥10.93 Billion | China | CN¥19.10 | -1.29% | -4.07% | 48.41 Million |
| 210 |
Galapagos NV
F:GXEA |
$1.60 Billion | €1.37 Billion | Germany | €23.20 | +0.00% | -5.69% | 0.00 |
| 211 |
Chengzhi Shareholding Co Ltd
SHE:000990 |
$1.58 Billion | CN¥10.80 Billion | China | CN¥6.35 | -2.61% | -2.76% | 1.04 Billion |
| 212 |
Mesoblast Limited
F:LWB |
$1.56 Billion | €1.34 Billion | Germany | €1.26 | -1.67% | -11.37% | 16.80K |
| 213 |
Galapagos N.V.
AS:GLPG |
$1.55 Billion | €1.33 Billion | Netherlands | €26.90 | +4.67% | +13.22% | 1.67 Million |
| 214 |
Staidson Beijing Biopharma
SHE:300204 |
$1.54 Billion | CN¥10.53 Billion | China | CN¥19.46 | -1.72% | -8.34% | 515.17 Million |
| 215 |
Pharma Mar S.A.
MC:PHM |
$1.54 Billion | €1.32 Billion | Spain | €76.15 | -0.39% | -7.36% | 840.68K |
| 216 |
Damora Therapeutics, Inc.
NASDAQ:DMRA |
$1.53 Billion | $1.53 Billion | USA | $24.75 | -12.82% | -17.66% | 9.89 Million |
| 217 |
Latigo Biotherapeutics, Inc. Common Stock
NASDAQ:LTGO |
$1.53 Billion | $1.53 Billion | USA | $23.01 | +1.63% | -0.13% | 4.95 Million |
| 218 |
Nanjing Vazyme Biotech Co Ltd
SHG:688105 |
$1.53 Billion | CN¥10.42 Billion | China | CN¥20.16 | -2.28% | +2.75% | 332.81 Million |
| 219 |
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN |
$1.52 Billion | $1.52 Billion | USA | $34.28 | -2.00% | -8.32% | 4.94 Million |
| 220 |
Innoviva Inc
NASDAQ:INVA |
$1.51 Billion | $1.51 Billion | USA | $20.84 | -0.29% | -2.30% | 14.79 Million |
| 221 |
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX |
$1.50 Billion | $1.50 Billion | USA | $22.67 | -2.28% | -2.16% | 12.44 Million |
| 222 |
OliX PharmaceuticalsInc
KQ:226950 |
$1.49 Billion | ₩2.20 Trillion | Korea | ₩108300.00 | +8.19% | +11.08% | 6.34 Million |
| 223 |
Galecto Inc
NASDAQ:GLTO |
$1.47 Billion | $1.47 Billion | USA | $24.45 | +1.33% | -4.72% | 7.16 Million |
| 224 |
uniQure N.V
F:UQ1 |
$1.46 Billion | €1.25 Billion | Germany | €37.30 | -3.49% | -3.87% | 1.16K |
| 225 |
Uniqure NV
NASDAQ:QURE |
$1.46 Billion | $1.46 Billion | USA | $43.10 | -4.07% | -3.15% | 26.73 Million |
| 226 |
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
$1.39 Billion | CN¥9.50 Billion | China | CN¥10.00 | -1.57% | -4.21% | 229.68 Million |
| 227 |
Nanobiotix S.A
PA:NANO |
$1.39 Billion | €1.19 Billion | France | €30.16 | -3.08% | -9.05% | 4.05 Million |
| 228 |
ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBP |
$1.38 Billion | $1.38 Billion | USA | $27.97 | -2.10% | -9.63% | 10.86 Million |
| 229 |
First Tracks Biotherapeutics
NASDAQ:TRAX |
$1.37 Billion | $1.37 Billion | USA | $38.47 | +2.40% | -4.92% | 13.56 Million |
| 230 |
Tyra Biosciences Inc
NASDAQ:TYRA |
$1.37 Billion | $1.37 Billion | USA | $25.43 | +1.44% | -11.24% | 23.23 Million |
| 231 |
IMMUNOCORE HLDGS ADS/1
F:6YG |
$1.36 Billion | €1.16 Billion | Germany | €24.80 | -1.59% | -7.46% | 4.72K |
| 232 |
Maze Therapeutics, Inc. Common Stock
NASDAQ:MAZE |
$1.35 Billion | $1.35 Billion | USA | $24.23 | -1.78% | -7.55% | 10.64 Million |
| 233 |
Absci Corp
NASDAQ:ABSI |
$1.35 Billion | $1.35 Billion | USA | $7.94 | -1.85% | -9.98% | 67.32 Million |
| 234 |
Intellia Therapeutics Inc
NASDAQ:NTLA |
$1.34 Billion | $1.34 Billion | USA | $11.36 | -4.30% | -10.83% | 78.27 Million |
| 235 |
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076 |
$1.32 Billion | CN¥9.04 Billion | China | CN¥28.54 | +1.03% | -0.80% | 61.32 Million |
| 236 |
Vor Biopharma Inc
NASDAQ:VOR |
$1.32 Billion | $1.32 Billion | USA | $22.32 | -3.29% | -10.90% | 17.70 Million |
| 237 |
Novavax Inc
NASDAQ:NVAX |
$1.31 Billion | $1.31 Billion | USA | $9.23 | -3.75% | -9.69% | 123.98 Million |
| 238 |
Inhibrx Biosciences, Inc.
NASDAQ:INBX |
$1.30 Billion | $1.30 Billion | USA | $105.61 | -4.40% | -12.84% | 8.22 Million |
| 239 |
Ultragenyx
NASDAQ:RARE |
$1.29 Billion | $1.29 Billion | USA | $13.07 | -3.97% | -14.58% | 99.82 Million |
| 240 |
ATAI LIFE SCIENCES BV EO1
F:9VC |
$1.29 Billion | €1.10 Billion | Germany | €3.55 | +0.00% | +4.76% | 69.10K |
| 241 |
Ascletis Pharma Inc
F:2VJ |
$1.28 Billion | €1.10 Billion | Germany | €1.04 | -2.80% | -6.31% | 0.00 |
| 242 |
Oric Pharmaceuticals Inc
NASDAQ:ORIC |
$1.28 Billion | $1.28 Billion | USA | $12.36 | -2.29% | -3.89% | 27.53 Million |
| 243 |
ATAI Life Sciences NV
XETRA:9VC |
$1.27 Billion | €1.09 Billion | Germany | €3.43 | -1.21% | -2.89% | 99.02K |
| 244 |
Omeros Corporation
NASDAQ:OMER |
$1.24 Billion | $1.24 Billion | USA | $17.17 | -1.66% | -9.39% | 52.04 Million |
| 245 |
Tourmaline Bio Inc.
NASDAQ:TRML |
$1.23 Billion | $1.23 Billion | USA | $47.98 | +0.00% | +0.02% | 13.86 Million |
| 246 |
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX |
$1.23 Billion | $1.23 Billion | USA | $22.96 | -7.04% | -7.64% | 3.37 Million |
| 247 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
$1.23 Billion | $1.23 Billion | USA | $12.76 | -0.93% | -8.14% | 17.52 Million |
| 248 |
Vcanbio Cell & Gene Engineering Corp Ltd
SHG:600645 |
$1.22 Billion | CN¥8.34 Billion | China | CN¥17.83 | -1.27% | -4.24% | 346.62 Million |
| 249 |
immatics biotechnologies GmbH
F:4A3 |
$1.22 Billion | €1.04 Billion | Germany | €7.38 | -2.06% | -11.41% | 4.24K |
| 250 |
NANOBIOTIX S.A. SP.ADR
F:5NRA |
$1.21 Billion | €1.04 Billion | Germany | €27.40 | +2.24% | -0.72% | 421.00 |
| 251 |
PATTIES FOODS
F:PH4 |
$1.21 Billion | €1.03 Billion | Germany | €0.65 | -1.47% | -0.22% | 4.00K |
| 252 |
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513 |
$1.20 Billion | CN¥8.17 Billion | China | CN¥46.30 | -2.63% | +0.35% | 55.48 Million |
| 253 |
HBM HLDGS LTD DL-000025
F:6XY |
$1.17 Billion | €1.00 Billion | Germany | €1.37 | -7.43% | -11.61% | 0.00 |
| 254 |
Beijing Hotgen Biotech Co Ltd
SHG:688068 |
$1.17 Billion | CN¥8.02 Billion | China | CN¥86.49 | -4.54% | -7.32% | 70.32 Million |
| 255 |
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG |
$1.17 Billion | $1.17 Billion | USA | $40.11 | -0.89% | -9.68% | 7.97 Million |
| 256 |
EVEREST MED.LTD DL-0001
F:6HN |
$1.16 Billion | €995.33 Million | Germany | €2.82 | -2.76% | -17.06% | 600.00 |
| 257 |
Jade Biosciences, Inc.
NASDAQ:JBIO |
$1.16 Billion | $1.16 Billion | USA | $18.18 | +1.62% | -15.05% | 18.32 Million |
| 258 |
MannKind Corp
NASDAQ:MNKD |
$1.14 Billion | $1.14 Billion | USA | $3.56 | -5.07% | -12.32% | 77.30 Million |
| 259 |
Day One Biopharmaceuticals Inc
NASDAQ:DAWN |
$1.13 Billion | $1.13 Billion | USA | $21.53 | +0.00% | +0.37% | 36.16 Million |
| 260 |
Aurisco Pharmaceutical Co Ltd
SHG:605116 |
$1.13 Billion | CN¥7.71 Billion | China | CN¥18.97 | -0.78% | -3.12% | 81.85 Million |
| 261 |
Aktis Oncology, Inc. Common stock
NASDAQ:AKTS |
$1.12 Billion | $1.12 Billion | USA | $22.41 | -3.28% | -17.15% | 6.86 Million |
| 262 |
Monte Rosa Therapeutics Inc
NASDAQ:GLUE |
$1.11 Billion | $1.11 Billion | USA | $12.99 | -6.55% | -6.14% | 25.59 Million |
| 263 |
Corvus Pharmaceuticals Inc
NASDAQ:CRVS |
$1.09 Billion | $1.09 Billion | USA | $12.95 | -1.22% | -10.01% | 19.25 Million |
| 264 |
Alumis Inc
NASDAQ:ALMS |
$1.09 Billion | $1.09 Billion | USA | $8.40 | -8.89% | -24.32% | 85.34 Million |
| 265 |
Savara Inc
NASDAQ:SVRA |
$1.08 Billion | $1.08 Billion | USA | $5.26 | -1.50% | -2.05% | 35.67 Million |
| 266 |
180 Life Sciences Corp
NASDAQ:ATNF |
$1.08 Billion | $1.08 Billion | USA | $16.80 | +905.99% | +667.12% | 221.50 Million |
| 267 |
SL Science Holding Limited Ordinary Shares
NASDAQ:SLBT |
$1.07 Billion | $1.07 Billion | USA | $1.91 | -7.73% | -33.68% | 1.71 Million |
| 268 |
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
$1.07 Billion | CN¥7.31 Billion | China | CN¥5.21 | -2.62% | -4.93% | 560.62 Million |
| 269 |
Apnimed, Inc. Common Stock
NASDAQ:APMD |
$1.06 Billion | $1.06 Billion | USA | $25.56 | +0.04% | -6.89% | 8.61 Million |
| 270 |
Innovita Biological Technology Co. Ltd. A
SHG:688253 |
$1.06 Billion | CN¥7.26 Billion | China | CN¥53.00 | -2.63% | -6.69% | 43.67 Million |
| 271 |
Obsidian Therapeutics, Inc. Common Stock
NASDAQ:OBX |
$1.05 Billion | $1.05 Billion | USA | $17.00 | -6.08% | +1.07% | 5.63 Million |
| 272 |
MoonLake Immunotherapeutics
NASDAQ:MLTX |
$1.04 Billion | $1.04 Billion | USA | $12.20 | -3.79% | -18.72% | 31.96 Million |
| 273 |
Blue Jet Healthcare Limited
NSE:BLUEJET |
$1.03 Billion | Rs95.52 Billion | India | Rs550.65 | -3.15% | -3.36% | 11.55 Million |
| 274 |
Iovance Biotherapeutics Inc
NASDAQ:IOVA |
$1.03 Billion | $1.03 Billion | USA | $9.36 | +1.08% | +6.48% | 348.01 Million |
| 275 |
Idorsia Ltd
SW:IDIA |
$1.03 Billion | CHF814.02 Million | Switzerland | CHF4.76 | -4.80% | -6.34% | 22.29 Million |
| 276 |
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294 |
$1.03 Billion | CN¥7.03 Billion | China | CN¥13.94 | -1.83% | -4.26% | 162.89 Million |
| 277 |
Attovia Therapeutics, Inc. Common Stock
NASDAQ:ATTO |
$1.03 Billion | $1.03 Billion | USA | $23.70 | -3.34% | -7.24% | 4.30 Million |
| 278 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
$1.03 Billion | $1.03 Billion | USA | $6.88 | +2.92% | -6.01% | 104.29 Million |
| 279 |
Starlake Bioscience Co Inc Zhaoqing Guangdong
SHG:600866 |
$1.01 Billion | CN¥6.93 Billion | China | CN¥4.17 | -2.80% | -5.66% | 634.86 Million |
| 280 |
Kura Oncology Inc
NASDAQ:KURA |
$1.01 Billion | $1.01 Billion | USA | $11.30 | -2.25% | -14.72% | 56.00 Million |
| 281 |
Ventyx Biosciences Inc
NASDAQ:VTYX |
$1.00 Billion | $1.00 Billion | USA | $14.00 | +0.00% | +0.29% | 71.70 Million |
| 282 |
Bio-Thera Solutions Ltd
SHG:688177 |
$997.36 Million | CN¥6.82 Billion | China | CN¥16.46 | -2.14% | -4.69% | 99.86 Million |
| 283 |
Seegene Inc
KQ:096530 |
$995.82 Million | ₩1.47 Trillion | Korea | ₩32250.00 | +0.94% | +2.71% | 8.75 Million |
| 284 |
Verve Therapeutics Inc
NASDAQ:VERV |
$994.04 Million | $994.04 Million | USA | $11.13 | +0.00% | +0.00% | 0.00 |
| 285 |
Gracell Biotechnologies Inc.
NASDAQ:GRCL |
$989.87 Million | $989.87 Million | USA | $562.10 | +0.20% | -4.73% | 53.25K |
| 286 |
INVENTIVA ADS/1 O.N.
F:6IVA |
$957.19 Million | €818.74 Million | Germany | €4.38 | -0.45% | -2.23% | 102.00 |
| 287 |
Fortrea Holdings Inc.
NASDAQ:FTRE |
$948.95 Million | $948.95 Million | USA | $19.73 | +13.33% | +11.47% | 28.79 Million |
| 288 |
Sana Biotechnology Inc
NASDAQ:SANA |
$945.98 Million | $945.98 Million | USA | $3.16 | -1.25% | -17.92% | 69.78 Million |
| 289 |
Chengdu Kanghua Biological Products
SHE:300841 |
$931.37 Million | CN¥6.36 Billion | China | CN¥48.98 | -1.57% | -3.94% | 112.36 Million |
| 290 |
SpyGlass Pharma, Inc.
NASDAQ:SGP |
$919.82 Million | $919.82 Million | USA | $28.96 | +1.05% | +0.07% | 2.07 Million |
| 291 |
Zhejiang Ausun Pharmaceutical Co Ltd
SHG:603229 |
$918.53 Million | CN¥6.28 Billion | China | CN¥7.56 | -0.92% | -4.06% | 177.32 Million |
| 292 |
Faeth Therapeutics, Inc.
NASDAQ:FTH |
$913.98 Million | $913.98 Million | USA | $35.37 | -9.52% | -11.69% | 7.26 Million |
| 293 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
$906.70 Million | $906.70 Million | USA | $5.06 | -1.36% | -1.75% | 110.36 Million |
| 294 |
Solid Biosciences LLC
NASDAQ:SLDB |
$897.48 Million | $897.48 Million | USA | $8.37 | -4.23% | -18.34% | 20.76 Million |
| 295 |
Cullinan Oncology LLC
NASDAQ:CGEM |
$894.21 Million | $894.21 Million | USA | $20.54 | +0.69% | -7.02% | 19.49 Million |
| 296 |
CureVac NV
F:5CV |
$885.32 Million | €757.26 Million | Germany | €3.91 | -0.61% | +10.78% | 458.08K |
| 297 |
PYC Therapeutics Ltd
AU:PYC |
$883.94 Million | AU$1.25 Billion | Australia | AU$2.26 | +1.35% | -9.96% | 79.06 Million |
| 298 |
Janux Therapeutics Inc
NASDAQ:JANX |
$878.78 Million | $878.78 Million | USA | $16.44 | -5.03% | -18.77% | 20.53 Million |
| 299 |
Ardelyx Inc
NASDAQ:ARDX |
$877.84 Million | $877.84 Million | USA | $3.40 | -3.41% | -10.05% | 94.69 Million |
| 300 |
ALPHAMAB ONCOLO.DL-000002
F:3NK |
$876.64 Million | €749.84 Million | Germany | €0.86 | -0.58% | -9.52% | 0.00 |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries